Inventor · disambiguated record
Rosanne M. Crooke
Also filed as: CROOKE ROSANNE · CROOKE ROSANNE M
52 granted patents·51 pending applications·1,628 citations·filing 2001–2025
99Inventor score
Files withISIS PHARMACEUTICALS INC36IONIS PHARMACEUTICALS INC28CROOKE ROSANNE M14GENZYME CORP6FREIER SUSAN M3
Top patents by PatentIndex Score
103 records- 0199US7741305B2Modulation of apolipoprotein (a) expressionISIS PHARMACEUTICALS INC·Filed 2007·Granted Jun 22, 2010·135 cites·27 claims
- 0298US7723508B2Modulation of apolipoprotein (A) expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted May 25, 2010·136 cites·24 claims
- 0398US7598227B2Modulation of apolipoprotein C-III expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Oct 6, 2009·292 cites·28 claims
- 0498US7425545B2Modulation of C-reactive protein expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Sep 16, 2008·158 cites·42 claims
- 0597US8093222B2Methods for treating hypercholesterolemiaFREIER SUSAN M·Filed 2009·Granted Jan 10, 2012·46 cites·68 claims
- 0697US7750141B2Modulation of apolipoprotein c-III expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 6, 2010·64 cites·18 claims
- 0797US7335764B2Antisense modulation of acyl CoA cholesterol acyltransferase-2 expressionISIS PHARMACEUTICALS INC·Filed 2007·Granted Feb 26, 2008·119 cites·25 claims
- 0896US8673632B2Modulation of apolipoprotein (a) expressionCROOKE ROSANNE M·Filed 2010·Granted Mar 18, 2014·27 cites·4 claims
- 0996US8138328B2Modulation of apolipoprotein (A) expressionCROOKE ROSANNE M·Filed 2010·Granted Mar 20, 2012·30 cites·18 claims
- 1096US7407943B2Antisense modulation of apolipoprotein B expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Aug 5, 2008·61 cites·65 claims
- 1196US7259150B2Modulation of apolipoprotein (a) expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Aug 21, 2007·48 cites·26 claims
- 1296US7202357B2Antisense modulation of acyl CoA cholesterol acyltransferase-2 expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Apr 10, 2007·118 cites·18 claims
- 1395US8859514B2Modulation of C-reactive protein expressionCROOKE ROSANNE M·Filed 2010·Granted Oct 14, 2014·28 cites·25 claims
- 1495US8084437B2Methods for treating hypercholesterolemiaFREIER SUSAN M·Filed 2007·Granted Dec 27, 2011·44 cites·19 claims
- 1595US7803930B2Antisense modulation of apolipoprotein B-expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Sep 28, 2010·40 cites·36 claims
- 1694US9957292B2Compositions and methods for modulating angiopoietin-like 3 expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted May 1, 2018·11 cites·81 claims
- 1794US9382540B2Compositions and methods for modulating angiopoietin-like 3 expressionISIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 5, 2016·13 cites·28 claims
- 1894US8653047B2Modulation of angiopoietin-like 3 expressionCROOKE ROSANNE M·Filed 2011·Granted Feb 18, 2014·18 cites·17 claims
- 1994US7863252B2Modulation of C-reactive protein expressionISIS PHARMACEUTICALS INC·Filed 2008·Granted Jan 4, 2011·22 cites·45 claims
- 2093US8664190B2Methods for treating hypercholesterolemiaFREIER SUSAN M·Filed 2011·Granted Mar 4, 2014·17 cites·13 claims
- 2193US2025313843A1Methods for treating hypercholesterolemiaIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2292US8530439B2Modulation of apolipoprotein C-III expressionCROOKE ROSANNE M·Filed 2010·Granted Sep 10, 2013·13 cites·48 claims
- 2392US7888324B2Antisense modulation of apolipoprotein B expressionGENZYME CORP·Filed 2001·Granted Feb 15, 2011·30 cites·20 claims
- 2492US7227014B2Antisense modulation of apolipoprotein (a) expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Jun 5, 2007·26 cites·25 claims
- 2591US10858657B2Methods for treating hypercholesterolemiaIONIS PHARMACEUTICALS INC·Filed 2018·Granted Dec 8, 2020·2 cites·18 claims
- 2691US7491815B2Antisense modulation of C-reactive protein expressionISIS PHARMACEUTICALS INC·Filed 2005·Granted Feb 17, 2009·10 cites·48 claims
- 2791US6964950B2Antisense modulation of C-reactive protein expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Nov 15, 2005·26 cites·37 claims
- 2891US6767739B2Antisense modulation of microsomal triglyceride transfer protein expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Jul 27, 2004·22 cites·13 claims
- 2988US11530410B2Methods for treating hypercholesterolemiaIONIS PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·1 cites·12 claims
- 3087US10875884B2Compositions and methods for modulating angiopoietin-like 3 expressionIONIS PHARMACEUTICALS INC·Filed 2018·Granted Dec 29, 2020·4 cites·22 claims
- 3187US9650636B2Methods for treating hypercholesterolemiaISIS PHARMACEUTICALS INC·Filed 2014·Granted May 16, 2017·5 cites·20 claims
- 3286US11634711B2Methods and compositions for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Apr 25, 2023·1 cites·20 claims
- 3386US9624496B2Modulation of apolipoprotein C-III expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Apr 18, 2017·3 cites·22 claims
- 3485US9574193B2Methods and compositions for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2014·Granted Feb 21, 2017·2 cites·25 claims
- 3585US8912160B2Methods for treating hypercholesterolemiaISIS PHARMACEUTICALS INC·Filed 2014·Granted Dec 16, 2014·4 cites·13 claims
- 3685US7132529B2Antisense modulation of stearoyl-CoA desaturase expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Nov 7, 2006·12 cites·10 claims
- 3785US2023137382A1Methods for treating hypercholesterolemiaIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3884US10478448B2Methods and compositions for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Nov 19, 2019·1 cites·25 claims
- 3984US9365848B2Modulation of apolipoprotein C-III expressionIONIS PHARMACEUTICALS INC·Filed 2013·Granted Jun 14, 2016·4 cites·16 claims
- 4083US7915231B2Antisense modulation of C-reactive protein expressionISIS PHARMACEUTICALS INC·Filed 2009·Granted Mar 29, 2011·3 cites·25 claims
- 4183US7326693B2Antisense modulation of c-reactive protein expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Feb 5, 2008·10 cites·16 claims
- 4283US2024067964A1Methods and compositions for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4382US9157082B2Modulation of apolipoprotein CIII (ApoCIII) expressionMULLICK ADAM·Filed 2012·Granted Oct 13, 2015·7 cites·45 claims
- 4482US9139831B2Modulation of angiopoietin-like 3 expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Sep 22, 2015·3 cites·29 claims
- 4581US9884072B2Methods and compositions for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Feb 6, 2018·1 cites·23 claims
- 4679US8735364B2Antisense modulation of apolipoprotein B expressionCROOKE ROSANNE M·Filed 2008·Granted May 27, 2014·2 cites·38 claims
- 4778US11225664B2Modulation of angiopoietin-like 3 expressionIONIS PHARMACEUTICALS INC·Filed 2019·Granted Jan 18, 2022·0 cites·17 claims
- 4878US10472629B2Methods and compositions for modlating apolipoprotein (A) expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Nov 12, 2019·1 cites·18 claims
- 4978USRE44760EAntisense modulation of apolipoprotein B-expressionGENZYME CORP·Filed 2012·Granted Feb 11, 2014·1 cites·58 claims
- 5078US8093224B2Antisense modulation of C-reactive protein expressionCROOKE ROSANNE M·Filed 2011·Granted Jan 10, 2012·2 cites·20 claims
Showing the top 50 of 103 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rosanne M. Crooke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →